Disclosed herein are α7β1 integrin modulatory agents and methods of using such to treat conditions associated with decreased α7β1 integrin expression or activity, including muscular dystrophy. In one example, methods for treating a subject with muscular dystrophy are disclosed. The methods include administering an effective amount of an α7β1 integrin modulatory agent to the subject with muscular dystrophy, wherein the α7β1 integrin modulatory agent increases α7β1 integrin expression or activity as compared to α7β1 integrin expression or activity prior to treatment, thereby treating the subject with muscular dystrophy. Also disclosed are methods of enhancing muscle regeneration, repair, or maintenance in a subject and methods of enhancing α7β1 integrin expression by use of the disclosed α7β1 integrin modulatory agents. Methods of prospectively preventing or reducing muscle injury or damage in a subject are also disclosed.
US9707210B2
申请人:——
公开号:US9707210B2
公开(公告)日:2017-07-18
US9980943B2
申请人:——
公开号:US9980943B2
公开(公告)日:2018-05-29
Synthesis of new pyrrolo- and thieno[2,3-b]pyridine derivatives by the Thorpe-Ziegler reaction
作者:M. Yu. Yakovlev、A. V. Kadushkin、V. G. Granik
DOI:10.1007/bf02218879
日期:1996.2
devoted to the synthesis of heteromonoand bicyclic systems through the ThorpeZiegler reaction [! -3]. This intramolecular cyclization process was used to obtain functionally substituted 3-aminopyrroles, 3-aminofurans, 3-aminothiophenes, and 4-aminoimidazoles, which were used as the initial compounds for the synthesis of various condensed heterocycles containing heteroaromatic five-membered ring fragments